Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.67 per share a year ago. These figures are ...

Reports FY24 revenue $25.3M, consensus $25.15M. “We are pleased with the significant PEMGARDA revenue growth of 48% in the fourth quarter, ...

2; affirms structural biology within Invivyd’s unique technology and reflects consi Invivyd (NasdaqGM:IVVD) has seen its share price surge by an impressive 163% over the past month, driven ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other micro and small-cap stocks. Nine micro-cap companies and one small-cap firm have been the ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other biotech stocks. No matter the market environment, you’ll always find entertainment in ...

Invivyd (IVVD) announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA against the currently dominant ...

Shares of IVVD stock opened at $1.30 on Monday. The business’s 50 day moving average is $0.82 and its two-hundred day moving average is $0.87. Invivyd has a twelve month low of $0.35 and a ...

The latest analyst rating for Invivyd (NASDAQ:IVVD) was provided by D. Boral Capital, and Invivyd maintained their buy rating. The last upgrade for Invivyd Inc happened on April 5, 2024 when ...

Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other micro and small-cap stocks. Nine micro-cap companies and one small-cap firm have been the ...